Frankfurt - Delayed Quote EUR
Clearbridge Health Limited (5C6.F)
0.0010
0.0000
(0.00%)
At close: April 30 at 3:29:02 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,903
9,903
10,407
16,412
11,442
Cost of Revenue
5,124
5,124
5,280
6,836
5,079
Gross Profit
4,779
4,779
5,127
9,576
6,363
Operating Expense
8,636
8,636
19,001
10,997
11,368
Operating Income
-3,857
-3,857
-13,874
-1,421
-5,005
Net Non Operating Interest Income Expense
-677
-677
-734
-791
-1,674
Pretax Income
-4,145
-4,145
-34,268
-11,237
-13,569
Tax Provision
67
67
-1,895
189
318
Net Income Common Stockholders
-3,608
-3,608
-32,199
-11,144
-19,970
Diluted NI Available to Com Stockholders
-3,608
-3,608
-32,199
-11,144
-19,970
Basic EPS
-0.00
-0.00
-0.03
-0.01
-0.02
Diluted EPS
-0.00
-0.00
-0.03
-0.01
-0.02
Basic Average Shares
1,237,057.2000
1,237,057.2000
1,113,730.2000
1,112,203.8000
1,110,844.8000
Diluted Average Shares
1,237,057.2000
1,237,057.2000
1,113,730.2000
1,112,203.8000
1,110,844.8000
Total Expenses
13,760
13,760
24,281
17,833
16,447
Net Income from Continuing & Discontinued Operation
-3,608
-3,608
-32,199
-11,144
-19,970
Normalized Income
-3,817.3400
-3,817.3400
-2,609.4811
-4,260.9500
-15,276.9100
Interest Income
--
--
166
75
48
Interest Expense
677
677
734
866
1,722
Net Interest Income
-677
-677
-734
-791
-1,674
EBIT
-3,468
-3,468
-33,534
-10,371
-11,847
EBITDA
-2,062
-2,062
-32,175
-7,630
-7,652
Reconciled Cost of Revenue
5,124
5,124
5,280
6,836
5,079
Reconciled Depreciation
1,406
1,406
1,359
2,741
4,195
Net Income from Continuing Operation Net Minority Interest
-3,653
-3,653
-32,105
-12,092
-15,711
Total Unusual Items Excluding Goodwill
198
198
-20,244
-9,435
-523
Total Unusual Items
198
198
-9,873
-9,435
-523
Normalized EBITDA
-2,260
-2,260
-22,302
1,805
-7,129
Tax Rate for Calcs
0.0002
0.0002
0.0001
0.0002
0.0002
Tax Effect of Unusual Items
33.6600
33.6600
-1,119.4811
-1,603.9500
-88.9100
12/31/2021 - 7/7/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade